-
Camrelizumab Combined with Gemcitabine and Albumin-Bound Paclitaxel in Pancreatic Cancer Patients with Liver Metastases: A Prospective, Pilot Trial
19 Jan 2026 18:46 GMT
… and non–small cell lung cancer.24 However, its combination … prior fluoropyrimidine- or gemcitabine-based therapy resulted in … non-squamous non-small-cell lung cancer (CameL): a randomised, … nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with …
-
A New Dawn in Cancer Treatment: How Targeted Protein Destruction Is Making Pancreatic Tumors Vanish
02 Feb 2026 15:54 GMT
… with KRAS G12C inhibitors in lung cancer, but the G12D variant, with … incidence compared to breast or lung cancer, pancreatic cancer’s high mortality … possible, chemotherapy with drugs like gemcitabine or FOLFIRINOX, and radiation therapy …
-
The Efficacy and Safety of Anlotinib Treatment for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Who Achieved Stable Disease (SD) After Two Cycles of First-Line Chemotherapy Combined with Immunotherapy: A Retrospective Cohort Study
14 Nov 2025 21:29 GMT
… A. Evolving trends in lung cancer: epidemiology, diagnosis, and … et al. Cisplatin and gemcitabine exert opposite effects on … advanced non-small cell lung cancer. Lung Cancer. 2018;122:32–37 … in non-small cell lung cancer (NSCLC). Lung Cancer. 2024;187:107438 …
-
Recent Advances in Mitochondria-Targeted Nano-Drug Delivery Systems for Cancer Therapy
02 Feb 2026 07:56 GMT
… for combating cisplatin-resistant lung cancer. ACS Nano. 2024 … chemo-synergistic therapies against lung cancer. Regen Biomater. 2022; … and suppress metastasis in lung cancer. J Nanobiotechnology. 2021 … stepwise response releasing gemcitabine and destroying the …
-
Patients with Advanced Non-Small Cell Lung Cancer and the EGFR Exon 19 Deletion p.L747 Benefit from Chemotherapy and First-Generation Tyrosine Kinase Inhibitors Compared with Patients with p.E746
06 Nov 2025 14:10 GMT
… First-line erlotinib versus gemcitabine/cisplatin in … mutant non-small cell lung cancer. Lung Cancer. 2014;86(2 … EGFR mutated lung cancers: correlation with clinical outcomes. Lung Cancer. 2017; … advanced non-small-cell lung cancer. Lung Cancer. 2022;166:9– …
-
Prospects and Challenges of Chitosan-Based Drug Carriers for Anticancer Agents’ Delivery Against Lung Cancer: A Review
24 Oct 2025 14:10 GMT
… lung cancer into non-small cell lung cancer (NSCLC) and small cell lung cancer … of lung cancer.
Current treatment modalities for lung cancer include … CPT-NPs inhibited lung tumor growth by … microzeolites for gemcitabine (GEM) delivery in lung cancer therapy. …
-
Prognostic Impact of Advanced Lung Cancer Inflammation Index (ALI) on Immunotherapy Outcomes in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Post Hoc Analysis
08 Oct 2025 06:55 GMT
… systemic inflammation. The Advanced Lung Cancer Inflammation Index (ALI … S, et al. Gemcitabine plus cisplatin versus fluorouracil … and advanced lung cancer inflammation index (ALI). Transl Lung Cancer Res. … mature neutrophils in lung cancer tissues impairs the …
-
Dermatotoxicity of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: Current Advances in Mechanistic Insights and Predictive Biomarker Identification
17 Sep 2025 09:09 GMT
… cells are enriched in lung tumors and inflammatory lung … -small cell lung cancer treated with nivolumab. Lung Cancer. 2019;132 … non-small cell lung cancer (NSCLC). Transl Lung Cancer Res. 2021; … combination with cisplatin plus gemcitabine in Japanese patients …
-
Emerging Targets in Non-Small Cell Lung Cancer
06 Sep 2025 06:12 GMT
… lung cancer (NSCLC) represents approximately 85% of all lung cancer … /ramucirumab, docetaxel, gemcitabine, and pemetrexed) in patients … non-small cell lung cancer: molecular mechanisms and … advanced non-small cell lung cancer. Lung Cancer. 2023;182:107291. …
-
HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025
05 Sep 2025 00:00 GMT
… 2025 World Conference on Lung Cancer (“WCLC”) taking place … in non-small cell lung cancer (“NSCLC”) patients will … 22
Poster: Small Cell Lung Cancer and Neuroendocrine Tumors
Tuesday, … of surufatinib combined with gemcitabine, cisplatin and immune checkpoint …
About
© 1995-2026